Valsartan/hydrochlorothiazide Ingen Pharma

Medicinal product

(Invented) name

Valsartan/hydrochlorothiazide Ingen Pharma

Active substance (s)

Valsartanas/Hidrochlorotiazidas

Strength

160 mg/25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA03, Valsartan and diuretics

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2012-10-12

Date of renewal

2017-10-16

Documents

3083 Pakuotės lapelis 2025 09 15.docx

3083 Valsartan_HCT Ingen Pharma PCS PL 2025 09 15.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Valsartanas	160 mg
Hidrochlorotiazidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
48534	62363	1062363	lizdinė plokštelė	N28		Receptinis	LT/1/12/3083/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-10-16	Perregistruotas
2012-10-12	Registruotas